The yorker that cleaned up Ollie Pope's stumps on Saturday, February 3, 2024 on Day 2 of the second England-India Test at the Dr Y S Rajasekhara Reddy ACA-VDCA cricket stadium in Visakhapatnam.
Market benchmark BSE Sensex rallied 635 points to 59,942 in the opening trade of the special Muhurat session on Monday to mark the beginning of Hindu Samvat year 2079. The 30-share index was trading higher by 635.12 points, or 1.07 per cent, at 59,942.27 in the first few minutes of trade. Similarly, the broader NSE Nifty surged 192.20 points or 1.09 per cent to 17,768.50.
Over the last five days, Modi visited all of south, held roadshows, made an aggressive bid for his party, and took on the rivals with full gusto, especially the ruling Dravida Munnetra Kazhagam in Tamil Nadu, and the Bharat Rashtra Samithi in Telangana that was in power for 10 years.
When elected on July 18 -- which is almost a certainty, given the NDA's numbers in the electoral college -- Droupadi Murmu will be the first President born after Independence.
Equity benchmark Sensex ended marginally higher after a choppy session on Friday as concerns over the economic impact of the second wave of Covid-19 and pace of vaccination weighed on investor sentiment.
The district revenue authorities have taken possession of the surrendered lands.
Let's delve into India's T20I track record against Australia
Dr Reddy has also cleared a proposal for a centre to provide training and guidance to meritorious minority youth both in civil services and other higher echelons.
Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.
The Andhra Pradesh government has decided to strengthen the police force in the state in view of terror attacks and Maoist violence.
Tech Mahindra was the top gainer in the Sensex pack, rising over 2 per cent, followed by HCL Tech, Infosys, L&T, Tata Steel and ITC. NSE Nifty advanced 41.60 points to 15,853.95.
Reserve Bank of India Governor Y V Reddy has been awarded an honorary fellowship by the prestigious London School of Economics and Political Science for his contribution to the cause of the under-privileged.
Equity benchmark Sensex slumped 400 points on Wednesday tracking losses in index majors HDFC twins, Kotak Bank and TCS amid a weak trend in global markets.
Construction major Larsen & Toubro invested $160.80 million in its wholly owned unit in the United Arab Emirates for business in financial services.
Many in the rallies Y S Sharmila Reddy has been addressing feel that she would be a better chief ministerial candidate than her mother in case Jaganmohan Reddy is not out of jail, reports Vicky Nanjappa
Representatives from seven vaccine makers -- Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech -- will be participating in the meeting.
Planning Commission Deputy Chairman Montek Singh Ahluwalia had misgivings on how and why the chief minister could raise so much money by selling government land, but eventually cleared the annual plan that was promised to be funded by a 32 per cent increase in the state's tax revenues. He put on record his doubts in a 3-page communication to the prime minister on April 23, 2008, a copy of which is with rediff.com
The Apollo Hospital in Hyderabad said it was not aware of any threat being issued to one of its doctors, who treated tennis star Sania Mirza.
On the Sensex chart, UltraTech Cement, HCL Tech, HDFC, Tech Mahindra, HDFC Bank and HUL emerged as the major laggards -- falling as much as 4.7 per cent. NSE Nifty dropped 63.05 points to end at 14,296.40.
Incumbent DMK MP T Sumathy alias Tamizhachi Thangapandian will face-off former Telangana Governor and BJP leader Tamilisai Soundararajan, while the the AIADMK has fielded ex-MP Dr J Jayavardhan, who won from here in 2014.
I suggest we build a Vigyan Mandir (Temple of Science) with the ambience of a place of worship, so that it becomes a destination for pilgrims. We should embed on its walls bronze plaques describing each scientist mentioned here along with about a dozen of our ancient mathematicians, recommends Professor Kalyan Singhal, historian of science and technology.
Equity benchmark Sensex slumped over 1,000 points to sink below the 55,000-level on Friday, tracking deep losses in IT, finance, banking and energy stocks amid widespread selling in the global markets. A weak rupee, surging crude prices and relentless foreign capital outflows further weighed on sentiment, traders said. The 30-share BSE index ended 1,016.84 points or 1.84 per cent lower at 54,303.44.
The Ranbaxy sale marks the end of a phase for Indian pharma, with the need to evolve the next.
As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.
Among the prominent gainers on the Sensex chart were Bajaj Finance, Bajaj FinServ, ICICI Bank, Axis bank, Tata Steel, IndusInd Bank and HDFC Bank -- rising as much as 3.50 per cent. NSE Nifty soared 271.65 points to settle at 17,625.70.
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.
The domestic benchmark indices - the S&P BSE Sensex and the National Stock Exchange Nifty50 - had lost close to 1.5 per cent in three days recently before gaining slightly. Notwithstanding weakness and volatility, the Nifty50 has managed to hold on to the 18,000 mark, while the Sensex has managed to stay above the 61,000 level. The performance of the stocks that comprise these front-line indices remains polarised.
Maruti was the top loser in the Sensex pack, shedding around 4 per cent, followed by Bharti Airtel, HUL, NTPC, Bajaj Finance, UltraTech Cement, ONGC and Reliance Industries. NSE Nifty declined 224.50 points to 14,324.90.
Notwithstanding the fact that the country's pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders predict that the overall domestic pharma industry will only witness a price hike of 5-6 per cent. This is attributed to higher competitive intensity in the market. Krishnakumar V, executive director and chief operating officer (CEO) of Eris Lifesciences, a domestic-focused pharma company, noted that the NLEM segment experienced growth suppression of around 150 basis points due to price reductions during the January to July period this year.
Reliance Industries was the top gainer in the Sensex pack, soaring nearly 6 per cent, followed by M&M, HDFC twins, Kotak Bank, ITC and Bharti Airtel.
Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Big companies like Cipla and Alkem have a significant presence in the segment but recently, players like Torrent Pharmaceuticals and Dr Reddy's Laboratories (DRL) have also entered this market. What is driving big pharma's focus on trade generics? The volume growth in the Indian Pharma Market (IPM) has come down from 5.6 per cent in FY16 to 0.1 per cent in FY23.
L&T was the top loser in the Sensex pack, shedding 1.56 per cent, followed by ICIC Bank, SBI, Kotak Bank, HDFC Bank, NTPC, Axis Bank and Bajaj Finserv. NSE Nifty slipped 19.05 points to 14,910.45.
Equity benchmark Sensex rallied over 300 points in opening trade on Monday, tracking gains in index majors HDFC twins, SBI and ICICI Bank amid mixed cues from global markets.
Dr Reddy's was the top gainer in the Sensex pack, rising over 3 per cent, followed by PowerGrid, TCS, HCL Tech, Infosys and Reliance Industries. On the other hand, L&T, IndusInd Bank, Bajaj Finserv and Bharti Airtel were among the laggards.
President Droupadi Murmu and Prime Minister Narendra Modi greeted the people of Telangana on the 10th State Formation Day while state Governor Tamilisai Soundararajan, Chief Minister K Chandrasekhar Rao and Union Minister for Tourism G Kishan Reddy separately hoisted the national flag on the occasion here on Friday.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances